Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PGEN Relative to the S&P 500

PGEN Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Precigen, Inc. (NASD:PGEN) seasonal charts above shows that a Buy Date of May 13 and a Sell Date of August 1 has resulted in a geometric average return of 13.25% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 45.96% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon’s business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company’s collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

To download PGEN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PGEN